{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-072151","form_type":"8-K","ticker":"OCUL","cik":"0001393434","company_name":"OCULAR THERAPEUTIX, INC","filed_at":"2022-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.454354+00:00","generated_at":"2026-06-25T00:47:33.231014+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ocular Therapeutix shareholders approve 3.6M share increase under 2021 Stock Incentive Plan","bullets":["Stockholders approved amendment to 2021 Stock Incentive Plan, increasing authorized shares by 3,600,000.","Elected Seung Suh Hong, Richard L. Lindstrom, and Leslie J. Williams as Class II directors until 2025.","Non-binding advisory vote on executive compensation passed: 31,197,580 for, 10,723,248 against.","Ratified PricewaterhouseCoopers as independent auditor for fiscal 2022 with 60,017,922 votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-072151","json":"https://secwatch.observer/filing/0001104659-22-072151.json","markdown":"https://secwatch.observer/filing/0001104659-22-072151.md","text":"https://secwatch.observer/filing/0001104659-22-072151.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1393434/000110465922072151/0001104659-22-072151-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1393434/000110465922072151/tm2218753d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:47:33.231014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}